More haste, less speed.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001315:Australia; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic; D004334:Drug Administration Schedule; D017277:Drug Approval; D000077156:Gefitinib; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced; D008175:Lung Neoplasms / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use*; D012107:Research Design; D017211:Treatment Failure; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib